DYAI
Dyadic International, Inc.
There isn't enough reported data to score DYAI yet.
DYAI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Weak | |
| Unavailable |
DYAI's revenue is currently stable, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
DYAI PE Valuation
DYAI has no meaningful PE right now: it lost money over the past year.
DYAI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect DYAI's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
DYAI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.21 | -$0.02 |
| Q1 2026 | -$0.21 | -$0.01 |
| Q4 2025 | -$0.23 | -$0.03 |
| Q3 2025 | -$0.24 | -$0.02 |
| Q2 2025 | -$0.19 | +$0.08 |
| Q1 2025 | -$0.20 | +$0.07 |
| Q4 2024 | -$0.20 | +$0.03 |
| Q3 2024 | -$0.22 | +$0.01 |
DYAI is still losing money, but far less than before: $0.21 per share over the past year, against $0.47 at its worst in late 2021.
DYAI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $961.1K | -0.6% |
| Q1 2026 | $1.1M | +182% |
| Q4 2025 | $565.5K | -31% |
| Q3 2025 | $1.2M | -41% |
| Q2 2025 | $966.6K | +150% |
| Q1 2025 | $393.6K | +18% |
| Q4 2024 | $817.4K | +19% |
| Q3 2024 | $2M | +393% |
DYAI's revenue has slid since its 2024 peak: $961,138 last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -214% | -35 points |
| Q1 2026 | -171% | +338 points |
| Q4 2025 | -272% | -84 points |
| Q3 2025 | -165% | -155 points |
| Q2 2025 | -179% | +350 points |
| Q1 2025 | -509% | +126 points |
| Q4 2024 | -187% | +129 points |
| Q3 2024 | -10% | +423 points |
DYAI's operating margin was −214% last quarter, down 35 points from the same quarter a year ago.
DYAI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.8M | -$1.7M |
| Q1 2026 | -$2M | -$13.6K |
| Q4 2025 | -$1.8M | -$1.1M |
| Q3 2025 | -$1.9M | -$1.7M |
| Q2 2025 | -$130K | +$1.8M |
| Q1 2025 | -$1.9M | -$836.8K |
| Q4 2024 | -$696.4K | +$227K |
| Q3 2024 | -$201.1K | +$1.8M |
DYAI has burned cash in almost every quarter: −$7M over the past year, against −$3M the year before.
DYAI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +40.7K shares |
| 1 year | +21% | +6.3M shares |
| 3 years | +26% | +7.6M shares |
| 5 years | +32% | +8.8M shares |
| Available history | +34% | +9.3M shares |
DYAI has 36M diluted shares, up 21% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
| Q3 2019 | — |
DYAI Net Leverage
DYAI's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DYAI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.7 | Neutral |
| Stochastic | 2.7 | Oversold |
DYAI's weekly RSI is 32 (neutral) and its Stochastic is 3 (oversold).
DYAI PE vs Healthcare Sector
DYAI has no meaningful PE right now: it lost money over the past year.
DYAI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.40 | 13% below |
| 20 week MA | $0.66 | 47% below |
| 50 week MA | $0.77 | 55% below |
| 100 week MA | $0.98 | 64% below |
| 200 week MA | $1.30 | 73% below |
DYAI is in a downtrend: it's below all five of its weekly moving averages, and 73% below its 200-week average.
DYAI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.28 | $5.57 | +5.5% |
| 2021 | $5.57 | $4.11 | -26% |
| 2022 | $4.11 | $1.37 | -67% |
| 2023 | $1.37 | $1.61 | +18% |
| 2024 | $1.61 | $1.96 | +22% |
| 2025 | $1.96 | $0.95 | -52% |
| 2026 YTD | $0.95 | $0.35 | -63% |
DYAI has finished lower in three of the last six years. It's down 63% so far in 2026.